Posted: April 15th, 2019
The Court of Milan departed from its previous position and decided that an urgent declaration of non-infringement can be granted even after the alleged infringer commenced marketing its product. Bisio Progetti S.p.A. (“Bisio”), a company active in the research and development of coffee and instant drink capsules, sought before the Court of Milan an urgent […]
READ MOREPosted: March 28th, 2019
ATK Race S.r.l. (“ATK Race”), the owner of the European patent no. EP 2.345.463 (“EP ‘463”), concerning a heel piece for an alpine ski attachment, brought an infringement action before the Court of Genoa against Fritschi AG Swiss Binfings (“Fritschi”), Nuovi Orizzonti s.a.s. of Rizzo Riccardo & C. (“Nuovi Orizzonti”) and Socrep S.r.l. (“Socrep”), which […]
READ MOREPosted: March 14th, 2019
Eli Lilly and Company, ICOS Corporation, and Eli Lilly Danmark A/S (“Eli Lilly”) v. Generics (UK) Limited and Mylan AB (“Mylan”), the Danish Maritime and Commercial High Court, Case number BS-33415/2018-SHR, 1 February 2019 The case concerns infringement of Eli Lilly’s patent DK/EP 1 173 181 T6 (“DK/EP ‘181”) which relates to the use of […]
READ MOREPosted: March 12th, 2019
Saima Sicurezza S.p.A. (“Saima”), a company active in the security sector, brought a patent infringement and unfair competition action before the Court of Milan against Plexa srl, Holacheck srl and Securconsult. The plaintiff is the owner of the Italian patent no. IT 1.396.496 (“IT ’496”), concerning a system for managing passenger access control in public […]
READ MOREPosted: February 26th, 2019
F. Hoffmann-La Roche AG and Genentech Inc. v. Mundipharma Pharmaceuticals B.V., Judge in interlocutory proceedings, District Court The Hague, The Netherlands, 20 February 2019, ECLI:NL:RBDHA:2019:1486 Preliminary injunction proceedings re biosimilar. Hoffmann-La Roche and Genentech both are part of the Roche group. Genentech developed Herceptin® for the treatment of breast cancer, with the anti-HER2 antibody trastuzumab […]
READ MOREPosted: January 7th, 2019
GSK v Vectura, Patents Court, London, UK, 13 December 2018, Case no. [2018] EWHC 3414 (Pat) This judgment is the first instance decision of Arnold J, dealing with GSK’s claim for revocation of five of Vectura’s patents and Vectura’s counterclaim for infringement by GSK’s dry powder inhaler products for the treatment of asthma and chronic […]
READ MOREPosted: November 14th, 2018
The UKSC has introduced a new test for the infringement of Swiss form second medical use claims and clarified the application of the test for plausibility of purpose-limited claims, by Tim Powell, Bethan Hopewell, Siddharth Kusumakar and Joel Coles, Powell Gilbert LLP The United Kingdom Supreme Court (UKSC) today handed down its highly-anticipated judgment in the […]
READ MOREPosted: November 7th, 2018
Coloplast A/S v. MacGregor Healthcare Limited, UK Intellectual Property Enterprise Court, 24 October 2018, [2018] EWHC 2797 (IPEC) This is a first instance decision from the UK Intellectual Property Enterprise Court “IPEC” on the validity and infringement of European Patent (UK) 1 145 729. The patent claimed a ready-to-use urinary catheter assembly which is stored […]
READ MOREPosted: November 6th, 2018
Icescape Limited v Ice-World International BV & Ors, Court of Appeal, London, UK, 10 October 2018, [2018] EWCA Civ 229 On 10 October 2018 the Court of Appeal handed down judgment in this case which concerned two companies both engaged in the making, operating and leasing of mobile ice rinks. Ice-World was the proprietor of […]
READ MORE
EMAIL US
